The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 8 Ways to Help Your Patients with Medication Costs

8 Ways to Help Your Patients with Medication Costs

October 18, 2018 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“Biosimilars may be priced lower than the reference biologic, but there will need to be better open access to the lower-cost alternative,” Dr. Perkins says.

You Might Also Like
  • Eli Lilly Backs U.S. Proposal on Drug Rebates to Lower Costs
  • Can Anything Contain Drug Costs in the U.S.?
  • Trump Administration Proposes Medicare Rules Aimed at Opioids, Drug Costs
Explore This Issue
October 2018
Also By This Author
  • 7 Tips That Dermatologists Want Rheumatologists to Know

Dr. Gibofsky envisions a time in the near future when some bio-originators will become lower in price to compete with biosimilars. “I haven’t yet seen a significant reduction in cost to the patient. It’s difficult to say to a patient, ‘I’m putting you on this drug to save money,’ when the savings aren’t realized by the patient,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The maze of prior authorization, insurance formularies & ever-changing drug costs has led … to frustration when rheumatologists get caught in the middle. Dr. Greer has had patients lash out at him when they haven’t received their medication.

What Patients Do to Cope

In a move to keep costs lower, rheumatologists have heard of patients who will use their prescribed drugs less frequently. “Patients with high yearly deductibles whose health is stable sometimes decide to forgo therapy in January, when the deductible renews and forces them to pay out of pocket,” Dr. Worthing says. “This often leads to disease flares weeks or months later.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Some patients who do self-injections of subcutaneous medications will do those injections less frequently than recommended. “They’ll find that sweet spot when it’s only just a little uncomfortable. They’ll take a dose every five to six weeks instead of every four weeks,” Dr. Gibofsky says. “There’s nothing more frustrating than that seesaw pattern. We often counsel patients that you may feel well, but that’s not a reason to interrupt your medications. We may be able to do that on a formal basis, but I don’t advise spacing out medications on an informal basis.”

Another move seen by rheumatologists is a reliance on nonapproved therapies instead of expensive medications, Dr. Greer says. He has seen patients who have felt reasonably better using such products as turmeric, fish oil or glucosamine chondroitin. “Some have a good benefit from them, but they don’t control diseases of a destructive nature,” he says.

What can rheumatologists do to help patients who can’t always afford their medications?

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

8 Tips to Help with Medication Costs

1. Explain why the drug is needed. This may not change a patient’s economic situation, but it does give insight into the cost-vs.-benefit issue, Dr. Perkins says. “I explain to the patient what medications are indicated for their illness that may be more affordable and why those medications may or may not be right for them. These lower-cost retail medications and generics may still be costly to the patient. In addition, it is important they realize if they require an advanced therapy that we term a specialty medication—even though they are very expensive to the plan—that ways [exist] to lower their out-of-pocket expense.”

Pages: 1 2 3 4 5 | Single Page

Filed Under: Drug Updates, Patient Perspective, Practice Management Tagged With: cost saving, drug costsIssue: October 2018

You Might Also Like:
  • Eli Lilly Backs U.S. Proposal on Drug Rebates to Lower Costs
  • Can Anything Contain Drug Costs in the U.S.?
  • Trump Administration Proposes Medicare Rules Aimed at Opioids, Drug Costs
  • Rheumatologists Concerned High Healthcare Costs May Encourage Patients to Forgo, Delay Treatment

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)